Neervannan Seshadri (CIK 1827584) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-24). Recent activity: Sell TARS (2,989 shares), Sell TARS (3,125 shares), Sell TARS (3,610 shares), Sell TARS (4,589 shares), Buy TARS (26,287 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-24 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 2,989 | $199,516 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 3,125 | $216,938 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 3,610 | $248,043 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 4,589 | $307,463 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Buy | 26,287 | $0 |
| 2026-03-05 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 8,366 | $641,421 |
| 2025-12-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 950 | $0 |
| 2025-12-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Buy | 475 | $0 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 2,605 | $120,585 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 2,543 | $120,538 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Sell | 2,435 | $122,018 |
| 2025-03-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Buy | 21,264 | $0 |
Source: SEC Form 4 filings · as of 2026-03-24